This June has been nothing more than Hunter Goodman proving he's the future of the Colorado Rockies franchise with his continuous power at the plate. As June nears its end, the Colorado Rockies find ...

Indianapolis-based Eli Lilly and Company gave an unidentified 79-year-old man exclusive access to its experimental obesity and diabetes drug, according to reporting by the life sciences media ...

When Dave Ricks became chief executive officer of Eli Lilly & Co. in 2017, he was facing an industry under siege. Americans held drug companies in lower esteem than airlines, law firms and even the ...

Saul Goodman must have gotten off on parole, as Bob Odenkirk suited up as the criminal lawyer for a “Know Your Rights” PSA celebrating America’s 250th birthday. “Hi, I’m Saul Goodman. Did you know you ...

Eli Lilly has signed a heavily backloaded agreement to license a gamma-secretase modulator treatment for Alzheimer's disease from AlzeCure Pharma for up to $1 billion biobucks. Lilly is obtaining the ...

Evangeline Lilly, who plays Hope van Dyne/Wasp in the Marvel Cinematic Universe, took to Instagram to blast Disney for firing Marvel employees amid the recent layoffs that saw 1,000 staffers let go ...

The Colorado Rockies have a superstar both behind the plate and in the box. Hunter Goodman put on a show on Wednesday evening against the Cincinnati Reds. He went 3-for-5 with two home runs, three RBI ...

Eli Lilly’s GLP-1 franchise brought in a total of $12.9 billion in sales in the first quarter as demand continued to soar for the drugs commonly used for weight loss. The drugmaker has three GLP-1 ...

April 28 (Reuters) - AI firm Profluent said on Tuesday it has struck a multi-program research collaboration with U.S. drugmaker Eli Lilly (LLY.N), opens new tab worth up ‌to $2.25 billion to develop ...

Eli Lilly said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up to $2.3 billion in cash, as the U.S. drugmaker looks to expand its oncology pipeline. Lilly has been ...

Stock prices are not measurements of expensiveness. Companies that compound earnings over decades naturally trade at high per-share prices if they've avoided stock splits or paid significant dividends ...

Eli Lilly (LLY) on Monday announced an agreement to acquire Kelonia Therapeutics, a privately held cancer drug developer, in a deal worth up to $7B in cash, confirming a prior report from The Wall ...